GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nolato AB (OSTO:NOLA B) » Definitions » Capex-to-Operating-Cash-Flow

Nolato AB (OSTO:NOLA B) Capex-to-Operating-Cash-Flow : 0.00 (As of Mar. 2025)


View and export this data going back to 1984. Start your Free Trial

What is Nolato AB Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Nolato AB's Capital Expenditure for the three months ended in Mar. 2025 was kr0.00 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2025 was kr135.00 Mil.

Hence, Nolato AB's Capex-to-Operating-Cash-Flow for the three months ended in Mar. 2025 was 0.00.


Nolato AB Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Nolato AB's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nolato AB Capex-to-Operating-Cash-Flow Chart

Nolato AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.64 1.12 0.55 0.47

Nolato AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nolato AB's Capex-to-Operating-Cash-Flow

For the Medical Devices subindustry, Nolato AB's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nolato AB's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Nolato AB's Capex-to-Operating-Cash-Flow falls into.


;
;

Nolato AB Capex-to-Operating-Cash-Flow Calculation

Nolato AB's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-640) / 1377
=0.46

Nolato AB's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / 135
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nolato AB  (OSTO:NOLA B) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Nolato AB Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Nolato AB's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Nolato AB Business Description

Traded in Other Exchanges
Address
Nolatovagen 32, Torekov, SWE, SE-269 78
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into three segments based on end market: Medical, which develops complex product systems, components, and packaging solutions for pharmaceuticals and supplements; Integrated, which develops subsystems for mobile phones; and Industrial, which develops systems for the automotive, hygiene, packaging, and furniture industries. Roughly a third of the firm's revenue is generated in the Rest of Europe.

Nolato AB Headlines

No Headlines